Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
1992-3-30
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0021-9150
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
267-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1793455-Adult,
pubmed-meshheading:1793455-Apolipoproteins E,
pubmed-meshheading:1793455-Female,
pubmed-meshheading:1793455-Gemfibrozil,
pubmed-meshheading:1793455-Humans,
pubmed-meshheading:1793455-Hypercholesterolemia,
pubmed-meshheading:1793455-Male,
pubmed-meshheading:1793455-Middle Aged
|
pubmed:year |
1991
|
pubmed:articleTitle |
Effects of gemfibrozil on serum apolipoprotein E distribution in hypercholesterolemic patients.
|
pubmed:publicationType |
Letter,
Research Support, Non-U.S. Gov't
|